Cannabinoid-based Active Pharmaceutical Ingredients
Xinteza is developing advanced proprietary biosynthesis and bioextraction technologies related to the production of cannabinoid-based active pharmaceutical ingredients (APIs) for the pharmaceutical and food industries. The company is engaged in the research and discovery of a wide array of new genes and ultra-novel genetic paths for the biosynthesis of cann…